Cannabis News Box

Tilray and Cronos report decline in per-gram weed prices

Tilray and Cronos report decline in per-gram weed prices

Bethan Rose Jenkins, Cannabis News Writer/Editorial

December 2, 2019

Two of Canada’s leading companies have reported a reduction in the per-gram price of cannabis in Canada’s legal market. Tilray, Inc. and Cronos Group released financial results for the third quarter on Tuesday, November 12.  Although both companies welcomed fair financial results, they each rep...

Tilray signs deal to purchase Canadian adult-use cannabis retailer

Tilray signs deal to purchase Canadian adult-use cannabis retailer

Bethan Rose Jenkins, Cannabis News Writer/Editorial

September 30, 2019

Major player in the Canadian legal cannabis space, Tilray, is broadening its horizons. The global leader in cannabis research, cultivation, production, and distribution has set its sights on Alberta, where a thriving adult-use market is transpiring. In its most recent deal, Tilray confirmed its entry into Alberta...

Cannabis cultivation market will soar to $45.4 billion by 2026

Cannabis cultivation market will soar to $45.4 billion by 2026

Bethan Rose Jenkins, Cannabis News Writer/Editorial

September 25, 2019

Cannabis cultivators are expected to reap what they sow on a monumental scale, what with market demand soaring. Based on a recent report by Grand View Research, Inc., the global market size for cultivation will top $45.4 billion by 2026. This figure suggests that the global cannabis cultivation market will i...

Cannabis firm Tilray is hiring Goldman Sachs’ former managing director

Cannabis firm Tilray is hiring Goldman Sachs’ former managing director

Bethan Rose Jenkins, Cannabis News Writer/Editorial

March 28, 2019

Leading Canadian cannabis cultivator Tilray has announced that it is hiring Goldman Sachs’ ex-managing director, Andrew Pucher, as the company’s chief corporate development officer. Pucher is the latest of numerous Wall Street executives to enter the legal weed industry in recent times. His ro...

FDA chief announces resignation, what will happen to the CBD review?

FDA chief announces resignation, what will happen to the CBD review?

Bethan Rose Jenkins, Cannabis News Writer/Editorial

March 22, 2019

Following the passing of the 2018 Farm Bill on December 12, 2018, hemp and hemp-derived CBD (cannabidiol) have been eliminated from the U.S. Controlled Substances Act. As a direct effect of this, the CBD industry looks set to skyrocket into otherworldly realms of success.  However, the recently...

Weed and fizzy drinks are being eyed up on Wall Street

Weed and fizzy drinks are being eyed up on Wall Street

Bethan Rose Jenkins, Cannabis News Writer/Editorial

February 24, 2019

Cannabis is a hot topic on Wall Street right now, where three cannabis stocks are currently trading on the New York Stock Exchange (NYSE). However, it’s not just weed that’s expected to shake up the stock market in 2019 but also, soda and video games. Let’s take a closer look at what Wall Stree...

Anheuser-Busch joins forces with Tilray to research cannabis-infused drinks

Anheuser-Busch joins forces with Tilray to research cannabis-infused drinks

Bethan Rose Jenkins, Cannabis News Writer/Editorial

January 7, 2019

A major investment is being funneled into the cannabis-infused drinks industry by two pioneers of the beer and weed worlds. Based on the details of a recent news release, Belgium-based Anheuser-Busch InBev (NYSE: BUD), and British Columbia-based Tilray (Nasdaq: TLRY) will invest $100 million in a pro...

Cannabis stocks plummet following Canada’s cannabis legalization

Cannabis stocks plummet following Canada’s cannabis legalization

Bethan Rose Jenkins, Cannabis News Writer/Editorial

October 26, 2018

Two of the biggest cannabis ETF's descended sharply on Monday when Canada's leading cannabis companies experienced losses of over 10 percent each. The ETFMG Alternative Harvest ETF, the biggest U.S. cannabis ETF, dropped to $33.99, a 9.36 percent decline. However, compared to some other cannabis stoc...

Germany will rely on Canadian-exported marijuana after judge halts licensing process

Germany will rely on Canadian-exported marijuana after judge halts licensing process

Bethan Rose Jenkins, Cannabis News Writer/Editorial

April 22, 2018

Germany's flourishing medical cannabis program will continue to source its plants from Canadian exports. This news comes after a court decision delayed the cultivation licensing procedure for the country. A judge from Dusseldorf Higher Regional Court demanded a halt on the licensing process. His argument st...

Canadian producer exports medical cannabis to New Zealand

Canadian producer exports medical cannabis to New Zealand

Sara Tiradossi

October 1, 2017

Tilray, a Canadian medical cannabis producer, has successfully exported its medical cannabis products to New Zealand. The products will be distributed to pharmacies that serve registered patients in New Zealand. Tilray President Brendan Kennedy said he is proud to offer patients in New Zealand...

Tilray